This content is from:365亚博 This Hedge Fund Is ‘Reasonably Confident’ a Covid-19 Vaccine Will Be Approved This Year MKP Capital has also calculated the odds of the FDA approving a vaccine before the U.S. presidential election. By克里斯汀Idzelis September 10, 2020
This content is from:Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. ByStephen Taub December 08, 2020
This content is from:Premium These Companies Yielded a Big Payday for Viking Global Investors Two IPOs in which the Tiger Cub held sizable stakes surged in price, while another smaller biopharma stake has more than doubled since going public. ByStephen Taub December 14, 2020
This content is from:365亚博 A Short Seller Claims a ‘Fictional Character’ Wrote This Company’s Medical Research Gabriel Grego’s second shot at medical devices company Penumbra hits its mark. ByMichelle Celarier December 08, 2020
This content is from:Premium Perceptive Advisors Posts Best Results Since 2000, Gaining 54% The life sciences firm is also raising money for a new credit fund. ByStephen Taub January 15, 2020
This content is from:Premium Sarissa’s Healthy Returns Follow Long Activist Campaign Sarissa founder Alex Denner, who previously worked for Icahn Capital, posted huge gains last year. BySteve Taub January 30, 2020
